Placenta Praevia in a Tertiary Hospital in Southern Nigeria: A Six-Year Review of Prevalence, Trend, and Risk Factors

Main Article Content

Felix Chikaike Clement Wekere
Kenneth Eghuan Okagua
Gift Anyanwu Clement-Wekere
Uduak Solomon Ocheche
Pius Ositadinma Mberekpe
Basil Omieibi Altriade
Rose Sitonma Iwo-Amah

Abstract

Background: Placenta praevia is a major cause of antepartum haemorrhage. It is associated with high foeto-maternal morbidity and mortality. The study was aimed at reviewing cases of placenta praevia managed at the Rivers State University Teaching Hospital (RSUTH) over 6 years, to determine the prevalence, trend, and sociodemographic/obstetrics factors. 


Methods: A descriptive cross-sectional study of all recorded cases of placenta praevia managed at RSUTH from 1st January 2016 to 31st December 2021. Descriptive and inferential statistics were derived using IBM, Statistical Product and Service Solution (SPSS) version 25.0 Armonk, NY.


Results: There were 14,195 deliveries and 137 cases of placenta praevia; giving the prevalence of 0.97% or 9.7 per 1000 or 1 in 103 deliveries The rate of placenta praevia per 1000 deliveries increased from 0.98 in 2016 to 3.03 in 2018 and then decreased to 1.54 in 2021. The mean (SD) age and gestational age of the participants were 32.5±4.9 (95% CI: 31.67, 33.34) years and 36.7 ±2.6 (95% CI: 36.34,37.10) weeks. The modal parity was para 1. The median blood loss was 600mls range 300-3,200 mls. The majority of the patients were booked 116 (84.7%), multiparas 65(47.4%) and had tertiary level education 56(40.9%). The most common risk factor identified was the history of a previous caesarean section 66(37.5%).


Conclusion: The prevalence of placenta previa in RSUTH is 0.97%; with a declining pattern of occurrence. Placenta praevia occurs more among multiparous women with a history of previous caesarean sections. Knowledge of this will be helpful to clinicians in making diagnosis and management of cases.

Article Details

How to Cite
Wekere, F. C. C. ., Kenneth Eghuan Okagua, Gift Anyanwu Clement-Wekere, Uduak Solomon Ocheche, Pius Ositadinma Mberekpe, Basil Omieibi Altriade, & Rose Sitonma Iwo-Amah. (2022). Placenta Praevia in a Tertiary Hospital in Southern Nigeria: A Six-Year Review of Prevalence, Trend, and Risk Factors . International Journal of Medical Science and Clinical Research Studies, 2(5), 350–354. https://doi.org/10.47191/ijmscrs/v2-i5-09
Section
Articles

References

I. Fan D, Wu S, Liu L, Xia Q, Wang W, Guo X, Liu Z: Prevalence of antepartum hemorrhage in women with placenta previa: a systematic review and meta-analysis. Scientific reports 2017, 7(1):1-9.

II. Balachandar K, Melov SJ, Nayyar R: The risk of adverse maternal outcomes in cases of placenta praevia in an Australian population between 2007 and 2017. Australian and New Zealand Journal of Obstetrics and Gynaecology 2020, 60(6):890-895.

III. Cresswell JA, Ronsmans C, Calvert C, Filippi V: Prevalence of placenta praevia by world region: a systematic review and meta‐analysis. Tropical medicine & international health 2013, 18(6):712-724.

IV. Wekere FCC, Kua PL, Akani A, Bademosi A: Prevalence, maternal and perinatal sequelae of antepartum haemorrhage in a tertiary hospital in South-South, Nigeria. International Journal of Clinical Obstetrics and Gynaecology 2021, 5(5):206-210.

V. Okafor II: Antepartum Haemorrhage. In: Our Teachers- A Comprehensive Textbook of Obstetrics and Gynaecology. First edn. Edited by Umeora OUJ, Egbuji C.C, Onyebuchi A.K, P.O E. Abakalik: ST. Benedict Printing and Publishing; 2017: 205-208.

VI. Moga M, Arvătescu C, Manea R, Bãlan A, Bîgiu N: RETROSPECTIVE STUDY REGARDING OUR EXPERIENCE IN SYMPTOMATIC PLACENTA PRAEVIA. Bulletin of the Transilvania University of Brasov Medical Sciences Series VI 2017, 10(2):55-66.

VII. Kwawukume EY, Omo-Aghoja LA: Antepartum Haemorrhage (APH). In: Comprehensive obstetrics in the tropics. Second edn. Edited by Kwawukume E, EE. E, Ekele B.A, KA D. Accra-North Ghana: Assemblies of God Literature Centre Ltd; 2015: 184-197.

VIII. Thera T, Teguete I, Kouma A: Maternal and Perinatal Outcome of Placenta Previa: 10 Years Analysis in the District of Bamako. of 2017, 4:2.

IX. Bowman ZS, Eller AG, Bardsley TR, Greene T, Varner MW, Silver RM: Risk factors for placenta accreta: a large prospective cohort. American journal of perinatology 2014, 31(09):799-804.

X. Badr DA, Al Hassan J, Wehbe GS, Ramadan MK: Uterine body placenta accreta spectrum: A detailed literature review. Placenta 2020, 95:44-52.

XI. Odelola O, Akadri A, Ogunsowo K: Placenta Praevia: A Retrospective Review of Experience at Olabisi Onabanjo University Teaching Hospital, Sagamu. West African Journal of Medicine 2019, 36(3):217-221.

XII. Chinedum NE, Chukwudi OR, Chinedum NG: Placenta Praevia: Diagnosis and Management outcomes in a Medical Centre, South East Nigeria. JMSCR 2018, 6(12):413-419.

XIII. Omokanye L, Olatinwo A, Salaudeen A, Ajiboye A, Durowade K: A 5-year review of pattern of placenta previa in Ilorin, Nigeria. International Journal of Health Sciences 2017, 11(2):35.

XIV. Saleh S, Ismaeel SK: Placenta Previa: Risk Factors, Maternal And Fetal Outcome-The Middle East Experience. Intl J Clin Diag Res 2018, 6(6).

XV. Ezechi OC, Kalu BK, Nwokoro CA, Njokanma FO, Loto OM, Okeke GC: Placenta praevia: a study of risk factors, maternal and fetal outcome. Tropical Journal of Obstetrics and Gynaecology 2004, 21(2):131-134.

XVI. Ayodeji OF, Oladoyin VO, Oloyede OA: Assessment of the Maternal Morbidity Profiles Associated with Placenta Praevia Occurring in Pregnancy With Previous Uterine Scar in a South-Western Nigerian Government Hospital. Tropical Journal of Obstetrics and Gynaecology 2020, 37(2):243-251.

XVII. Wekere FCC, Iwo-Amah RS, Kwosah JN, Bademosi A, Amadi SC: A Five-Year Review of Caesarean Section at the Rivers State University Teaching Hospital, South-South, Nigeria. Journal of Advances in Medicine and Medical Research 2021, 33(23):159-167.

XVIII. Memon E, Ashfaq S, Naqvi KZ, Sultan S, Aziz S, Irfan SM: Maternal Outcome in Morbidly Adherent Placenta in Obstetrics Patients. Journal of The Society of Obstetricians and Gynaecologists of Pakistan 2017, 7(2):85-88.

XIX. Latif L, Iqbal UJ, Aftab MU: Associated risk factors of placenta previa a matched case control study. Pakistan Journal of Medical and Health Sciences 2015, 9(4):1344-1346.

XX. Senkoro EE, Mwanamsangu AH, Chuwa FS, Msuya SE, Mnali OP, Brown BG, Mahande MJ: Frequency, risk factors, and adverse fetomaternal outcomes of placenta previa in Northern Tanzania. Journal of pregnancy 2017, 2017.

XXI. Halimi S: ASSOCIATION OF PLACENTA PREVIA WITH MULTIPARITY AND PREVIOUS CESAREAN SECTION. JPMI: Journal of Postgraduate Medical Institute 2011, 25(2).

XXII. Anzaku A, Musa J: Placenta praevia: incidence, risk factors, maternal and fetal outcomes in a Nigerian teaching hospital. Jos Journal of Medicine 2012, 6(1):42-46.

XXIII. Burodo A, Shehu C: Placenta praevia at Usmanu Danfodiyo University Teaching Hospital, Sokoto: A 5-year review. Sahel Medical Journal 2013, 16(2):56.